US 11975106
Uses of halogenated xanthenes in oncology and virology
granted A61KA61K2039/55511A61K31/35
Quick answer
US patent 11975106 (Uses of halogenated xanthenes in oncology and virology) held by Provectus Pharmatech, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/55511, A61K31/35, A61K31/352, A61K31/706